| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af737d167c026fd865fb68df681ea49a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
1990-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c6b5d1afbb774bf0d4925d97427004a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51e17dc3e57ab9fbf78a10dbe3d1266
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ae15d39a3b896464211159b3501585 |
| publicationDate |
1999-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-215913-B |
| titleOfInvention |
A method for the preparation of a pharmaceutical composition for the elimination of cancer cell (multidrog) resistance containing toremifene and its metabolites. |
| abstract |
The present invention relates to a process for the preparation of pharmaceutical compositions containing thoremifent or its metal salts prepared in a known manner, N-demethyl-doremififen or 4-hydroxytoremifen, or non-toxic pharmaceutically acceptable salts thereof. The process according to the invention is carried out by mixing the abovementioned active ingredients with excipients and / or auxiliaries which are suitable for medical purposes and formulating them into a composition which is suitable for reducing the resistance of several cytotoxic agents. ŕ |
| priorityDate |
1989-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |